Business PR Newswire Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances rvrisingnetwork October 21, 2025 0 SHANGHAI, Oct. 19, 2025 /PRNewswire/ — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to... Read More Read more about Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
